Please use this identifier to cite or link to this item:
Title: Vitamin E TPGS based Nanomedicine for Multimodality Treatment of Cancer
Authors: MI YU
Keywords: nanomedicine, cancer nanotechnology, combination therapy, multimodality treatment, vitamin E TPGS, drug delivery
Issue Date: 19-Jul-2013
Citation: MI YU (2013-07-19). Vitamin E TPGS based Nanomedicine for Multimodality Treatment of Cancer. ScholarBank@NUS Repository.
Abstract: Cancer is a leading disease for mortality. In the past 30 years, the standard treatments have been surgery followed by radiotherapy and/or chemotherapy. If they fail, patients have a less than 10% chance of survival with other treatments. None of the existing single modality treatments, such as chemotherapy, radiotherapy, hyperthermia therapy, immunotherapy, anti-angiogenesis therapy or gene therapy can cure cancer. It is also unlikely that any magic anticancer drug can be discovered in the next few years to completely cure cancer, since the problems in drug delivery would always be there. Instead, multimodality treatment can do an excellent job, superior to any single modality treatment in current practice. Multimodality treatment has been investigated for their synergistic effects that may dramatically improve outcomes and reduce the side effects of each single modality treatment. To better achieve the multimodality treatment of cancer, nanomedicine can provide a fantastic platform for multimodality treatment.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
MiY.pdf4.03 MBAdobe PDF



Page view(s)

checked on Jun 7, 2020


checked on Jun 7, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.